Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022

SELL
$11.78 - $16.98 $412,300 - $594,300
-35,000 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$12.22 - $19.57 $244,400 - $391,400
20,000 Added 133.33%
35,000 $490,000
Q3 2021

Nov 15, 2021

SELL
$15.42 - $21.72 $308,400 - $434,400
-20,000 Reduced 57.14%
15,000 $281,000
Q2 2021

Aug 16, 2021

BUY
$20.85 - $29.88 $729,750 - $1.05 Million
35,000 New
35,000 $730,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $738M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.